Ministry of Health: pharmaceutical companies can reproduce almost the entire range of foreign drugs
The Russian pharmaceutical industry can reproduce almost the entire range of foreign drugs, Deputy Minister of Health Sergei Glagolev said...
The Russian pharmaceutical industry can reproduce almost the entire range of foreign drugs, Deputy Minister of Health Sergei Glagolev said...
+ A - The Russian government has expanded the list of essential medicines Prime Minister Mikhail Mishustin ordered the expansion...
Medicines for the treatment of children with severe and chronic diseases have been added to the list of vital and...
The end of the pandemic and the period of rush demand resulted in a decrease in sales of the largest...
Despite the high potential for import substitution, Russian production is experiencing an acute shortage of domestic equipment comparable to imported...
The White House is preparing to submit amendments to the Code of Administrative Offenses to the State Duma, allowing judges...
The government has extended simplified procedures for registering and importing medicines until the end of 2024, Prime Minister Mikhail Mishustin...
The evacuated residents of the Shebekinsky urban district can receive the necessary medicines and medical services free of charge. About...
Despite the fact that medicines are essentials, many Russians start saving their family budget with them. There are even those...
The neurotech company Neuralink, which is owned by SpaceX founder and Twitter owner Elon Musk and produces brain chips, has...
In May 2023, the median inflation expected by the population in a year, according to FOM estimates for the Central...
In the first quarter, Russian pharmacies sold 37.2 million packages of COVID-19 medicine, 31% less than in the same period...
The Ministry of Health, the Ministry of Finance and the Federal Antimonopoly Service are discussing the possibility of a risk-sharing...
The early onset of spring and the long absence of rains led to a surge in demand for allergy medicines:...
"Evergreen patents" that pharmaceutical companies receive from Rospatent after the expiration of the main registration, making minor changes to the...